Ask AI

Metabolic Connections: Rethinking MASLD, MASH, and Obesity in an Evolving Management Landscape

Investigate metabolic pathways linking obesity, liver health, and cardiovascular risk and improve your recognition and management of metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH). Access a ClinicalThought expert commentary, downloadable slides, and an on-demand webcast to learn about the latest guidelines, best practices, and evidence for screening, risk assessment, and advanced therapies in patients with obesity who are at risk for or who have MASLD.

Share

Program Content

Events

Activities

MASLD, MASH, and Obesity Evolving Management
Metabolic Connections: Rethinking MASLD, MASH, and Obesity in an Evolving Management Landscape 
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.